Effect of a diffusional barrier to a metabolite across hepatocytes on its kinetics in “enzyme-distributed” models: A computer-aided simulation study
- 31 July 1987
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 15 (4) , 399-421
- https://doi.org/10.1007/bf01066521
Abstract
The effect of a diffusional barrier to a metabolite between the blood and hepatocytes on elimination kinetics of formed and preformed metabolites was predicted under various enzymic distributions in the liver by computer- aided simulation. Sequential metabolism by which the primary metabolite (MI) is generated from the parent drug (D) and further metabolized to the terminal metabolite (MII) by enzymes A and B, respectively, was chosen for the simulation. Moreover, four models of enzymic distribution patterns were defined with regard to the hepatic blood flow path. The extraction ratios for the preformed and formed metabolites (designated as Em and Ep→m, respectively) were simulated by varying both the average intrinsic clearance of enzyme B ( $\overline {CL_{int,B} }$ ) and the permeability of hepatocytes for MI ( $\overline {P_m }$ ), while keeping the average intrinsic clearance of enzyme A ( $\overline {CL_{int,A} }$ ) equal to hepatic blood flow (Q). When a rapid equilibrium of MI between the blood and hepatocytes held, i.e., $\overline {P_m }$ was large relative to Q, Em was equal to or higher than Ep→m for all models, as previously shown by Pang and Stillwell. By contrast, it was found that when a diffusional barrier for MI existed, i.e., $\overline {P_m }$ was small relative to Q, Em was equal to or lower than Ep→m. Furthermore, it was observed that the smaller $\overline {P_m }$ became, the larger the difference between Em and Ep→m became. We further simulated the effect of the intrinsic clearance ( $\overline {CL_{int,C} }$ ) for a metabolic pathway, which competes for that by enzyme A. on the E p→m value. In the model assuming even distribution of all the enzymes along the flow path, irrespective of the $\overline {CL_{int,C} }$ value, a similar effect of $\overline {P_m }$ on Ep→m was observed when the $\overline {P_m }$ value was relatively small ( $\overline {P_m }< Q$ ). By contrast, in the case of uneven enzymic distributions of enzymes A and B, the effect of the $\overline {CL_{int,C} }$ value on the relationship between Pm and Ep→m occurred to some extent. From these simulations, it was concluded that lower membrane permeability ( $\overline {P_m }$ ) both diminishes the entry of preformed metabolite into the hepatocytes and accelerates the removal of intracellularly formed metabolite (through sequential metabolism) by diminishing its efflux, yielding lower Em than Ep→m. When $\overline {P_m }$ becomes small ( $\overline {P_m }< 1/10Q$ ), these mechanisms for lower Em than Ep→m predominate over other mechanisms such as the presence of a competing metabolic route and uneven distribution of enzymes.
Keywords
This publication has 27 references indexed in Scilit:
- Effect of diffusional barriers on drug and metabolite kinetics.1987
- Presence of a diffusional barrier on metabolite kinetics: enalaprilat as a generated versus preformed metabolite.1986
- METABOLISM OF ACETAMINOPHEN AND PHENACETIN BY ISOLATED RAT HEPATOCYTES - A SYSTEM IN WHICH THE SPATIAL-ORGANIZATION INHERENT IN THE LIVER IS DISRUPTED1985
- EFFECTS OF PHENOBARBITAL AND 3-METHYLCHOLANTHRENE PRETREATMENTS ON MONOOXYGENASE ACTIVITIES AND PROPORTIONS OF ISOLATED RAT HEPATOCYTE SUBPOPULATIONS1983
- METABOLISM OF HARMOL AND TRANSPORT OF HARMOL CONJUGATES IN ISOLATED RAT HEPATOCYTES1983
- RATES OF SULFATION AND GLUCURONIDATION OF 7-HYDROXYCOUMARIN IN PERIPORTAL AND PERICENTRAL REGIONS OF THE LIVER LOBULE1982
- UPTAKE OF GALACTOSE, OUABAIN AND TAUROCHOLATE INTO CENTRILOBULAR AND PERIPORTAL ENRICHED HEPATOCYTE SUB-POPULATIONS1981
- Uptake of unconjugated bilirubin by isolated rat hepatocytesAmerican Journal of Physiology-Cell Physiology, 1979
- Immunohistochemical localizations of cytochromes P-450 in rat liverLife Sciences, 1978
- The convulsant potency of lidocaine and its N-dealkylated metabolites.1973